Journal Club 2026

Next HOPA Journal Club

Tuesday, January 13, 2026 at 2 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Orange button that says click here to register

The moderator for January's Journal Club session is:

Carissa Ganihog, PharmD, BCOP, Hackensack University Medical Center, Hackensack, NJ

January's Journal Club presenters include:

Priscilla Bang, PharmD

PGY2 Oncology Pharmacy Resident

Keiser Permanente San Diego, San Diego, CA

Article:

Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer

Maxwell Herbert, PharmD

PGY2 Oncology Pharmacy Resident

University of Virginia Medical Center, Charlottesville, VA

Article:

Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation

Featured Articles

Membership

Getting Away From the Guilt Trip: Reflections on Balancing Family Life with Our Livelihood

December 22, 2025

In response to December's episode of the HOPA Now Podcast, HOPA Wellness Advisory Group member Teresa Kam Thakrar contributed the following personal reflection about balancing family with a career in oncology pharmacy.

HOPA News

Late-Breaking HOPA News: Belantamab Mafodotin-bmlf Returns: FDA Restores BCMA-Targeted ADC Option for RRMM

December 17, 2025

Marshall Winget, PharmD, and Bradley Yelvington, PharmD, BCOP, discuss the recent reapproval of belantamab mafodotin in BCMA-directed therapy for relapsed or refractory multiple myeloma.

An image of acute lymphoblastic leukemia cells

Tools and Resources

Pharmacist's Application to Practice: Obecabtagene autoleucel

December 16, 2025

Crystal Chung, PharmD, PGY2 Oncology Pharmacy Resident, and Emma Sheldon, PharmD, BCOP, Oncology Pharmacy Specialist - Bone Marrow Transplant/Cellular Therapy, both from Scripps Health in San Diego, CA, discuss obecabtagene autoleucel (Aucatzyl).